nodes	percent_of_prediction	percent_of_DWPC	metapath
Lincomycin—Clindamycin—CYP3A4—type 2 diabetes mellitus	0.0198	1	CrCbGaD
Lincomycin—Abdominal pain—Acarbose—type 2 diabetes mellitus	0.00293	0.00299	CcSEcCtD
Lincomycin—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.00293	0.00298	CcSEcCtD
Lincomycin—Agranulocytosis—Glyburide—type 2 diabetes mellitus	0.00288	0.00294	CcSEcCtD
Lincomycin—Urticaria—Nateglinide—type 2 diabetes mellitus	0.00284	0.0029	CcSEcCtD
Lincomycin—Tinnitus—Bromocriptine—type 2 diabetes mellitus	0.00283	0.00289	CcSEcCtD
Lincomycin—Abdominal pain—Nateglinide—type 2 diabetes mellitus	0.00283	0.00288	CcSEcCtD
Lincomycin—Vertigo—Glipizide—type 2 diabetes mellitus	0.00282	0.00288	CcSEcCtD
Lincomycin—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.00281	0.00287	CcSEcCtD
Lincomycin—Leukopenia—Glipizide—type 2 diabetes mellitus	0.00281	0.00287	CcSEcCtD
Lincomycin—Nausea—Miglitol—type 2 diabetes mellitus	0.0028	0.00286	CcSEcCtD
Lincomycin—Liver function test abnormal—Metformin—type 2 diabetes mellitus	0.00278	0.00284	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Gliclazide—type 2 diabetes mellitus	0.00275	0.00281	CcSEcCtD
Lincomycin—Angioedema—Pioglitazone—type 2 diabetes mellitus	0.00275	0.0028	CcSEcCtD
Lincomycin—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00273	0.00279	CcSEcCtD
Lincomycin—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.00273	0.00279	CcSEcCtD
Lincomycin—Pruritus—Tolazamide—type 2 diabetes mellitus	0.00273	0.00279	CcSEcCtD
Lincomycin—Abdominal discomfort—Orlistat—type 2 diabetes mellitus	0.00271	0.00276	CcSEcCtD
Lincomycin—Jaundice—Gliclazide—type 2 diabetes mellitus	0.0027	0.00276	CcSEcCtD
Lincomycin—Vertigo—Pioglitazone—type 2 diabetes mellitus	0.0027	0.00276	CcSEcCtD
Lincomycin—Angioedema—Glimepiride—type 2 diabetes mellitus	0.00268	0.00273	CcSEcCtD
Lincomycin—Rash—Tolbutamide—type 2 diabetes mellitus	0.00268	0.00273	CcSEcCtD
Lincomycin—Neutropenia—Valsartan—type 2 diabetes mellitus	0.00267	0.00273	CcSEcCtD
Lincomycin—Angioedema—Sitagliptin—type 2 diabetes mellitus	0.00267	0.00272	CcSEcCtD
Lincomycin—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.00264	0.00269	CcSEcCtD
Lincomycin—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.00263	0.00269	CcSEcCtD
Lincomycin—Liver function test abnormal—Irbesartan—type 2 diabetes mellitus	0.00262	0.00268	CcSEcCtD
Lincomycin—Vertigo—Sitagliptin—type 2 diabetes mellitus	0.00262	0.00268	CcSEcCtD
Lincomycin—Leukopenia—Glimepiride—type 2 diabetes mellitus	0.00262	0.00267	CcSEcCtD
Lincomycin—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.00261	0.00267	CcSEcCtD
Lincomycin—Agranulocytosis—Gliclazide—type 2 diabetes mellitus	0.00259	0.00264	CcSEcCtD
Lincomycin—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.00254	0.00259	CcSEcCtD
Lincomycin—Pruritus—Nateglinide—type 2 diabetes mellitus	0.00253	0.00258	CcSEcCtD
Lincomycin—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00252	0.00257	CcSEcCtD
Lincomycin—Shock—Glipizide—type 2 diabetes mellitus	0.00252	0.00257	CcSEcCtD
Lincomycin—Abdominal discomfort—Metformin—type 2 diabetes mellitus	0.0025	0.00255	CcSEcCtD
Lincomycin—Urticaria—Repaglinide—type 2 diabetes mellitus	0.00246	0.00251	CcSEcCtD
Lincomycin—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.00245	0.0025	CcSEcCtD
Lincomycin—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.00245	0.0025	CcSEcCtD
Lincomycin—Abdominal pain—Repaglinide—type 2 diabetes mellitus	0.00245	0.0025	CcSEcCtD
Lincomycin—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.00245	0.0025	CcSEcCtD
Lincomycin—Neutropenia—Metformin—type 2 diabetes mellitus	0.00243	0.00248	CcSEcCtD
Lincomycin—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00243	0.00248	CcSEcCtD
Lincomycin—Rash—Tolazamide—type 2 diabetes mellitus	0.00243	0.00248	CcSEcCtD
Lincomycin—Rash—Linagliptin—type 2 diabetes mellitus	0.00241	0.00246	CcSEcCtD
Lincomycin—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00241	0.00246	CcSEcCtD
Lincomycin—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.00239	0.00244	CcSEcCtD
Lincomycin—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.00238	0.00243	CcSEcCtD
Lincomycin—Vertigo—Bromocriptine—type 2 diabetes mellitus	0.00237	0.00242	CcSEcCtD
Lincomycin—Vomiting—Acarbose—type 2 diabetes mellitus	0.00236	0.00241	CcSEcCtD
Lincomycin—Erythema multiforme—Gliclazide—type 2 diabetes mellitus	0.00236	0.0024	CcSEcCtD
Lincomycin—Shock—Glimepiride—type 2 diabetes mellitus	0.00235	0.0024	CcSEcCtD
Lincomycin—Rash—Acarbose—type 2 diabetes mellitus	0.00234	0.00239	CcSEcCtD
Lincomycin—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00234	0.00238	CcSEcCtD
Lincomycin—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.00232	0.00237	CcSEcCtD
Lincomycin—Tinnitus—Gliclazide—type 2 diabetes mellitus	0.00232	0.00237	CcSEcCtD
Lincomycin—Neutropenia—Irbesartan—type 2 diabetes mellitus	0.0023	0.00234	CcSEcCtD
Lincomycin—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00229	0.00234	CcSEcCtD
Lincomycin—Nausea—Tolazamide—type 2 diabetes mellitus	0.00229	0.00234	CcSEcCtD
Lincomycin—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00228	0.00233	CcSEcCtD
Lincomycin—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00227	0.00232	CcSEcCtD
Lincomycin—Rash—Nateglinide—type 2 diabetes mellitus	0.00225	0.0023	CcSEcCtD
Lincomycin—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00225	0.0023	CcSEcCtD
Lincomycin—Hypotension—Glimepiride—type 2 diabetes mellitus	0.00223	0.00228	CcSEcCtD
Lincomycin—Angioedema—Glyburide—type 2 diabetes mellitus	0.00221	0.00225	CcSEcCtD
Lincomycin—Nausea—Acarbose—type 2 diabetes mellitus	0.0022	0.00225	CcSEcCtD
Lincomycin—Pain—Glipizide—type 2 diabetes mellitus	0.00219	0.00223	CcSEcCtD
Lincomycin—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00219	0.00223	CcSEcCtD
Lincomycin—Leukopenia—Glyburide—type 2 diabetes mellitus	0.00216	0.00221	CcSEcCtD
Lincomycin—Jaundice—Irbesartan—type 2 diabetes mellitus	0.00214	0.00218	CcSEcCtD
Lincomycin—Nausea—Nateglinide—type 2 diabetes mellitus	0.00212	0.00217	CcSEcCtD
Lincomycin—Shock—Bromocriptine—type 2 diabetes mellitus	0.00212	0.00216	CcSEcCtD
Lincomycin—Liver function test abnormal—Ramipril—type 2 diabetes mellitus	0.00212	0.00216	CcSEcCtD
Lincomycin—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00212	0.00216	CcSEcCtD
Lincomycin—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00207	0.00211	CcSEcCtD
Lincomycin—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.00204	0.00209	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	0.00204	0.00209	CcSEcCtD
Lincomycin—Pain—Sitagliptin—type 2 diabetes mellitus	0.00204	0.00208	CcSEcCtD
Lincomycin—Urticaria—Glipizide—type 2 diabetes mellitus	0.00203	0.00208	CcSEcCtD
Lincomycin—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.00202	0.00207	CcSEcCtD
Lincomycin—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00201	0.00206	CcSEcCtD
Lincomycin—Jaundice—Losartan—type 2 diabetes mellitus	0.00201	0.00205	CcSEcCtD
Lincomycin—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.002	0.00204	CcSEcCtD
Lincomycin—Angioedema—Gliclazide—type 2 diabetes mellitus	0.00198	0.00202	CcSEcCtD
Lincomycin—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00197	0.00201	CcSEcCtD
Lincomycin—Rash—Repaglinide—type 2 diabetes mellitus	0.00195	0.00199	CcSEcCtD
Lincomycin—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00195	0.00199	CcSEcCtD
Lincomycin—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.00195	0.00199	CcSEcCtD
Lincomycin—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.00194	0.00198	CcSEcCtD
Lincomycin—Shock—Glyburide—type 2 diabetes mellitus	0.00194	0.00198	CcSEcCtD
Lincomycin—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.00192	0.00196	CcSEcCtD
Lincomycin—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.0019	0.00194	CcSEcCtD
Lincomycin—Urticaria—Glimepiride—type 2 diabetes mellitus	0.0019	0.00194	CcSEcCtD
Lincomycin—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00189	0.00193	CcSEcCtD
Lincomycin—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.00189	0.00193	CcSEcCtD
Lincomycin—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00189	0.00193	CcSEcCtD
Lincomycin—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.00188	0.00192	CcSEcCtD
Lincomycin—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.00188	0.00192	CcSEcCtD
Lincomycin—Neutropenia—Ramipril—type 2 diabetes mellitus	0.00185	0.00189	CcSEcCtD
Lincomycin—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00184	0.00188	CcSEcCtD
Lincomycin—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00184	0.00188	CcSEcCtD
Lincomycin—Hypotension—Glyburide—type 2 diabetes mellitus	0.00184	0.00188	CcSEcCtD
Lincomycin—Nausea—Repaglinide—type 2 diabetes mellitus	0.00184	0.00188	CcSEcCtD
Lincomycin—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.00183	0.00187	CcSEcCtD
Lincomycin—Angioedema—Valsartan—type 2 diabetes mellitus	0.00182	0.00186	CcSEcCtD
Lincomycin—Pruritus—Glipizide—type 2 diabetes mellitus	0.00181	0.00185	CcSEcCtD
Lincomycin—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00181	0.00184	CcSEcCtD
Lincomycin—Angioedema—Orlistat—type 2 diabetes mellitus	0.0018	0.00184	CcSEcCtD
Lincomycin—Vertigo—Valsartan—type 2 diabetes mellitus	0.00179	0.00183	CcSEcCtD
Lincomycin—Vertigo—Orlistat—type 2 diabetes mellitus	0.00177	0.0018	CcSEcCtD
Lincomycin—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00176	0.0018	CcSEcCtD
Lincomycin—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00176	0.00179	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.00175	0.00179	CcSEcCtD
Lincomycin—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00175	0.00179	CcSEcCtD
Lincomycin—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.00175	0.00179	CcSEcCtD
Lincomycin—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00174	0.00177	CcSEcCtD
Lincomycin—Tinnitus—Losartan—type 2 diabetes mellitus	0.00173	0.00176	CcSEcCtD
Lincomycin—Jaundice—Ramipril—type 2 diabetes mellitus	0.00172	0.00176	CcSEcCtD
Lincomycin—Stomatitis—Ramipril—type 2 diabetes mellitus	0.00172	0.00176	CcSEcCtD
Lincomycin—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00171	0.00175	CcSEcCtD
Lincomycin—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.0017	0.00174	CcSEcCtD
Lincomycin—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.0017	0.00174	CcSEcCtD
Lincomycin—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00169	0.00173	CcSEcCtD
Lincomycin—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00168	0.00171	CcSEcCtD
Lincomycin—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00165	0.00169	CcSEcCtD
Lincomycin—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.00165	0.00168	CcSEcCtD
Lincomycin—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00164	0.00167	CcSEcCtD
Lincomycin—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00163	0.00166	CcSEcCtD
Lincomycin—Vomiting—Glipizide—type 2 diabetes mellitus	0.00163	0.00166	CcSEcCtD
Lincomycin—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00163	0.00166	CcSEcCtD
Lincomycin—Rash—Glipizide—type 2 diabetes mellitus	0.00161	0.00165	CcSEcCtD
Lincomycin—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00161	0.00165	CcSEcCtD
Lincomycin—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00161	0.00164	CcSEcCtD
Lincomycin—Shock—Valsartan—type 2 diabetes mellitus	0.0016	0.00163	CcSEcCtD
Lincomycin—Urticaria—Glyburide—type 2 diabetes mellitus	0.00157	0.0016	CcSEcCtD
Lincomycin—Angioedema—Irbesartan—type 2 diabetes mellitus	0.00156	0.0016	CcSEcCtD
Lincomycin—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00156	0.00159	CcSEcCtD
Lincomycin—Vertigo—Irbesartan—type 2 diabetes mellitus	0.00154	0.00157	CcSEcCtD
Lincomycin—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.00153	0.00156	CcSEcCtD
Lincomycin—Nausea—Glipizide—type 2 diabetes mellitus	0.00152	0.00155	CcSEcCtD
Lincomycin—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00152	0.00155	CcSEcCtD
Lincomycin—Hypotension—Valsartan—type 2 diabetes mellitus	0.00152	0.00155	CcSEcCtD
Lincomycin—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00151	0.00155	CcSEcCtD
Lincomycin—Pain—Gliclazide—type 2 diabetes mellitus	0.00151	0.00154	CcSEcCtD
Lincomycin—Rash—Glimepiride—type 2 diabetes mellitus	0.00151	0.00154	CcSEcCtD
Lincomycin—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00151	0.00154	CcSEcCtD
Lincomycin—Rash—Sitagliptin—type 2 diabetes mellitus	0.0015	0.00153	CcSEcCtD
Lincomycin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.0015	0.00153	CcSEcCtD
Lincomycin—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.0015	0.00153	CcSEcCtD
Lincomycin—Tinnitus—Ramipril—type 2 diabetes mellitus	0.00148	0.00151	CcSEcCtD
Lincomycin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00148	0.00151	CcSEcCtD
Lincomycin—Angioedema—Losartan—type 2 diabetes mellitus	0.00147	0.0015	CcSEcCtD
Lincomycin—Shock—Metformin—type 2 diabetes mellitus	0.00146	0.00149	CcSEcCtD
Lincomycin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00145	0.00148	CcSEcCtD
Lincomycin—Vertigo—Losartan—type 2 diabetes mellitus	0.00145	0.00148	CcSEcCtD
Lincomycin—Leukopenia—Losartan—type 2 diabetes mellitus	0.00144	0.00147	CcSEcCtD
Lincomycin—Nausea—Glimepiride—type 2 diabetes mellitus	0.00142	0.00145	CcSEcCtD
Lincomycin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00142	0.00144	CcSEcCtD
Lincomycin—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00141	0.00143	CcSEcCtD
Lincomycin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.0014	0.00143	CcSEcCtD
Lincomycin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.0014	0.00143	CcSEcCtD
Lincomycin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.0014	0.00143	CcSEcCtD
Lincomycin—Pruritus—Glyburide—type 2 diabetes mellitus	0.00139	0.00142	CcSEcCtD
Lincomycin—Hypotension—Metformin—type 2 diabetes mellitus	0.00138	0.00141	CcSEcCtD
Lincomycin—Shock—Irbesartan—type 2 diabetes mellitus	0.00137	0.0014	CcSEcCtD
Lincomycin—Pain—Orlistat—type 2 diabetes mellitus	0.00137	0.0014	CcSEcCtD
Lincomycin—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00137	0.0014	CcSEcCtD
Lincomycin—Rash—Bromocriptine—type 2 diabetes mellitus	0.00136	0.00139	CcSEcCtD
Lincomycin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00136	0.00139	CcSEcCtD
Lincomycin—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00135	0.00138	CcSEcCtD
Lincomycin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00132	0.00134	CcSEcCtD
Lincomycin—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00131	0.00133	CcSEcCtD
Lincomycin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.0013	0.00133	CcSEcCtD
Lincomycin—Shock—Losartan—type 2 diabetes mellitus	0.00129	0.00132	CcSEcCtD
Lincomycin—Urticaria—Valsartan—type 2 diabetes mellitus	0.00129	0.00132	CcSEcCtD
Lincomycin—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00129	0.00131	CcSEcCtD
Lincomycin—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00128	0.00131	CcSEcCtD
Lincomycin—Urticaria—Orlistat—type 2 diabetes mellitus	0.00128	0.0013	CcSEcCtD
Lincomycin—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00127	0.0013	CcSEcCtD
Lincomycin—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00127	0.0013	CcSEcCtD
Lincomycin—Angioedema—Ramipril—type 2 diabetes mellitus	0.00126	0.00129	CcSEcCtD
Lincomycin—Vomiting—Glyburide—type 2 diabetes mellitus	0.00125	0.00128	CcSEcCtD
Lincomycin—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00125	0.00128	CcSEcCtD
Lincomycin—Rash—Glyburide—type 2 diabetes mellitus	0.00124	0.00127	CcSEcCtD
Lincomycin—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00124	0.00127	CcSEcCtD
Lincomycin—Vertigo—Ramipril—type 2 diabetes mellitus	0.00124	0.00127	CcSEcCtD
Lincomycin—Leukopenia—Ramipril—type 2 diabetes mellitus	0.00124	0.00126	CcSEcCtD
Lincomycin—Hypotension—Losartan—type 2 diabetes mellitus	0.00123	0.00125	CcSEcCtD
Lincomycin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00121	0.00124	CcSEcCtD
Lincomycin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.0012	0.00122	CcSEcCtD
Lincomycin—Pain—Irbesartan—type 2 diabetes mellitus	0.00119	0.00122	CcSEcCtD
Lincomycin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00118	0.00121	CcSEcCtD
Lincomycin—Urticaria—Metformin—type 2 diabetes mellitus	0.00118	0.0012	CcSEcCtD
Lincomycin—Nausea—Glyburide—type 2 diabetes mellitus	0.00117	0.00119	CcSEcCtD
Lincomycin—Abdominal pain—Metformin—type 2 diabetes mellitus	0.00117	0.00119	CcSEcCtD
Lincomycin—Pruritus—Valsartan—type 2 diabetes mellitus	0.00115	0.00117	CcSEcCtD
Lincomycin—Pruritus—Orlistat—type 2 diabetes mellitus	0.00114	0.00116	CcSEcCtD
Lincomycin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.00113	0.00115	CcSEcCtD
Lincomycin—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00113	0.00115	CcSEcCtD
Lincomycin—Pain—Losartan—type 2 diabetes mellitus	0.00112	0.00115	CcSEcCtD
Lincomycin—Rash—Gliclazide—type 2 diabetes mellitus	0.00112	0.00114	CcSEcCtD
Lincomycin—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00111	0.00114	CcSEcCtD
Lincomycin—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00111	0.00114	CcSEcCtD
Lincomycin—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00111	0.00113	CcSEcCtD
Lincomycin—Shock—Ramipril—type 2 diabetes mellitus	0.00111	0.00113	CcSEcCtD
Lincomycin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.0011	0.00113	CcSEcCtD
Lincomycin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.0011	0.00113	CcSEcCtD
Lincomycin—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.0011	0.00112	CcSEcCtD
Lincomycin—Hypotension—Ramipril—type 2 diabetes mellitus	0.00105	0.00107	CcSEcCtD
Lincomycin—Nausea—Gliclazide—type 2 diabetes mellitus	0.00105	0.00107	CcSEcCtD
Lincomycin—Pruritus—Metformin—type 2 diabetes mellitus	0.00105	0.00107	CcSEcCtD
Lincomycin—Urticaria—Losartan—type 2 diabetes mellitus	0.00104	0.00107	CcSEcCtD
Lincomycin—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00104	0.00106	CcSEcCtD
Lincomycin—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00104	0.00106	CcSEcCtD
Lincomycin—Vomiting—Valsartan—type 2 diabetes mellitus	0.00103	0.00105	CcSEcCtD
Lincomycin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00103	0.00105	CcSEcCtD
Lincomycin—Rash—Valsartan—type 2 diabetes mellitus	0.00103	0.00105	CcSEcCtD
Lincomycin—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00102	0.00105	CcSEcCtD
Lincomycin—Vomiting—Orlistat—type 2 diabetes mellitus	0.00102	0.00104	CcSEcCtD
Lincomycin—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00101	0.00103	CcSEcCtD
Lincomycin—Rash—Orlistat—type 2 diabetes mellitus	0.00101	0.00103	CcSEcCtD
Lincomycin—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00101	0.00103	CcSEcCtD
Lincomycin—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000989	0.00101	CcSEcCtD
Lincomycin—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000969	0.000988	CcSEcCtD
Lincomycin—Nausea—Valsartan—type 2 diabetes mellitus	0.000966	0.000985	CcSEcCtD
Lincomycin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000956	0.000975	CcSEcCtD
Lincomycin—Nausea—Orlistat—type 2 diabetes mellitus	0.000954	0.000974	CcSEcCtD
Lincomycin—Vomiting—Metformin—type 2 diabetes mellitus	0.000941	0.000961	CcSEcCtD
Lincomycin—Rash—Metformin—type 2 diabetes mellitus	0.000934	0.000953	CcSEcCtD
Lincomycin—Dermatitis—Metformin—type 2 diabetes mellitus	0.000933	0.000952	CcSEcCtD
Lincomycin—Pruritus—Losartan—type 2 diabetes mellitus	0.00093	0.000949	CcSEcCtD
Lincomycin—Diarrhoea—Losartan—type 2 diabetes mellitus	0.0009	0.000918	CcSEcCtD
Lincomycin—Urticaria—Ramipril—type 2 diabetes mellitus	0.000896	0.000914	CcSEcCtD
Lincomycin—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000891	0.000909	CcSEcCtD
Lincomycin—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000891	0.000909	CcSEcCtD
Lincomycin—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000888	0.000906	CcSEcCtD
Lincomycin—Rash—Irbesartan—type 2 diabetes mellitus	0.000881	0.000899	CcSEcCtD
Lincomycin—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00088	0.000898	CcSEcCtD
Lincomycin—Nausea—Metformin—type 2 diabetes mellitus	0.00088	0.000897	CcSEcCtD
Lincomycin—Vomiting—Losartan—type 2 diabetes mellitus	0.000836	0.000853	CcSEcCtD
Lincomycin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000831	0.000848	CcSEcCtD
Lincomycin—Nausea—Irbesartan—type 2 diabetes mellitus	0.00083	0.000847	CcSEcCtD
Lincomycin—Rash—Losartan—type 2 diabetes mellitus	0.000829	0.000846	CcSEcCtD
Lincomycin—Dermatitis—Losartan—type 2 diabetes mellitus	0.000828	0.000845	CcSEcCtD
Lincomycin—Pruritus—Ramipril—type 2 diabetes mellitus	0.000798	0.000814	CcSEcCtD
Lincomycin—Nausea—Losartan—type 2 diabetes mellitus	0.000781	0.000797	CcSEcCtD
Lincomycin—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000772	0.000787	CcSEcCtD
Lincomycin—Vomiting—Ramipril—type 2 diabetes mellitus	0.000717	0.000731	CcSEcCtD
Lincomycin—Rash—Ramipril—type 2 diabetes mellitus	0.000711	0.000725	CcSEcCtD
Lincomycin—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00071	0.000725	CcSEcCtD
Lincomycin—Nausea—Ramipril—type 2 diabetes mellitus	0.00067	0.000683	CcSEcCtD
